March 11 (Reuters) - FORFARMERS NV FFARM.AS :
* FY REVENUE 2.4 BILLION EUR
* FY UNDERLYING EBITDA:+8,7% TO EUR 96.2 MILLION; COMPARED
TO A
WEAK 2019
* FY GROSS PROFIT: -1.7% TO EUR 433.2 MILLION
* FY UNDERLYING NET PROFIT3:+10.0% TO EUR 46.3 MILLION
* FY DIVIDEND PROPOSAL: REGULAR DIVIDEND SUBSTANTIALLY
HIGHER AT
EUR 0.29 PER ORDINARY SHARE
* FY NET CASH FLOW FROM OPERATING ACTIVITIES:+2.1% TO EUR
98.1
MILLION
* OBJECTIVES 2025 : UNDERLYING EBITDA IN 2025 OF IN BETWEEN
€125
MILLION AND €135 MILLION, BOTH BY MEANS OF ORGANIC GROWTH AND
THROUGH ACQUISITIONS
* OBJECTIVES 2025 ANNUAL LIKE-FOR-LIKE IMPROVEMENT OF
UNDERLYING
EBITDA OF 0%-3% (AS OF 2020) IN CHALLENGING HOME COUNTRIES
* OBJECTIVES 2025: AT LEAST €10 MILLION OPERATING COST
SAVINGS IN
2025 (COMPARED TO NORMALISED LEVEL OF 2020)
* FORFARMERS EXPERIENCED HARDLY ANY DISRUPTION TO ITS
OPERATING
PROCESSES AS A RESULT OF COVID MEASURES
* OUTLOOK : THE COMPANY PLANS TO INVEST APPROXIMATELY €35
MILLION
IN 2021
* DUE TO THE CORONAVIRUS, THE ABSENTEE RATE IN 2020 WAS 3%,
COMPARED TO 2.5% IN 2019
* OUTLOOK : FORFARMERS WILL ALSO CONTINUE TO PURSUE
ACQUISITIONS
* COVID-19: DECLINE IN DEMAND FOR PRODUCTS FROM FARMERS
MEANT THAT
FORFARMERS DID EXPERIENCE PRESSURE ON VOLUMES
* FORFARMERS DOES NOT PROVIDE GUIDANCE FOR THE CURRENT
CALENDAR
YEAR
* OUTLOOK : FORFARMERS HAS SUFFICIENT FINANCIAL HEADROOM TO
REALISE HER GROWTH PLANS
* COVID-19: MARGINS ALSO COMING UNDER PRESSURE IN THE SECOND
HALF
OF 2020
* AS OF 31 DECEMBER 2020 DEBT /UNDERLYING EBITDA RATIO WAS
NEGATIVE 0.17
* COVID-19: MARGINS ALSO COMING UNDER PRESSURE ESPECIALLY
IN
POLAND AND THE UNITED KINGDOM
* COVID-19: DIFFICULT TO INDICATE EXACTLY WHAT PART OF
VOLUME
DECLINE CAN BE ATTRIBUTED TO COVID-19
* IN 2020, THERE WAS ALSO MARGIN PRESSURE DUE TO OTHER
FACTORS
INCLUDING ANIMAL DISEASES IN SOME MARKETS AND REGULATION EFFECTS
ESPECIALLY IN NETHERLANDS
* OBJECTIVES 2025 : THE FIRST STEP OF THIS OBJECTIVE IS TO
REDUCE
OPERATING EXPENSES BY €7 MILLION IN 2021 AND 2022, OF WHICH THE
FULL EFFECT WILL BE VISIBLE IN 2023
Source text for Eikon: ID:nGNEcffljH
Further company coverage: FFARM.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))